title: Recurrence of persistent polyclonal B lymphocytosis (PPBL) after rituximab treatment.
authors: Center for Chronic Immunodeficiency (CCI), University Medical Center Freiburg, University of Freiburg, Breisacherstrasse 117, 79106, Freiburg, Germany.
authors: C
authors: C
authors: Wehr
authors: L
authors: L
authors: Houet
authors: M
authors: M
authors: Pantic
authors: S
authors: S
authors: Gutenberger
authors: F
authors: F
authors: Emmerich
authors: R
authors: R
authors: Marks
authors: P
authors: P
authors: Fisch
authors: Klaus
authors: K
authors: Warnatz
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008218:Lymphocytosis / Q000175:diagnosis* / Q000188:drug therapy*; D012008:Recurrence; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab